The effect of screening on treatment cost: The case of colorectal cancer
Eline Aas ()
No 2008:5, HERO Online Working Paper Series from University of Oslo, Health Economics Research Programme
This paper presents a medical cost function developed for a screening programme. The medical cost function is a function of advancement both directly and indirectly through survival. We discuss how the medical cost function is affected by screening through a shift in the distribution of cancers according to advancement. We show that screening reduces the treatment cost for cancers diagnosed at the screening, even though the medical cost function not unambiguously increases with stage of advancement. This is the first step in a cost-effectiveness analysis, and even though the results are favourable to the introduction of screening for colorectal cancer as a preventive health measure, total screening costs and health benefits must be evaluated to arrive at a recommendation.
Keywords: treatment cost; stage of advancement; screening; probabilistic sensitivity analysis; bootstrap method (search for similar items in EconPapers)
JEL-codes: C41 H42 I10 I12 (search for similar items in EconPapers)
Pages: 39 pages
New Economics Papers: this item is included in nep-hea
References: Add references at CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:hhs:oslohe:2008_005
Access Statistics for this paper
More papers in HERO Online Working Paper Series from University of Oslo, Health Economics Research Programme HERO / Department of Health Management and Health Economics P.O. Box 1089 Blindern, N-0317 Oslo, Norway. Contact information at EDIRC.
Bibliographic data for series maintained by Kristi Brinkmann Lenander ().